SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-119726
Filing Date
2023-11-20
Accepted
2023-11-20 07:05:19
Documents
14
Period of Report
2023-11-20
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2331130d1_8k.htm   iXBRL 8-K 23336
2 EXHIBIT 99.1 tm2331130d1_ex99-1.htm EX-99.1 13695
6 GRAPHIC tm2331130d1_ex99-1img01.jpg GRAPHIC 12556
  Complete submission text file 0001104659-23-119726.txt   235195

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA pmn-20231120.xsd EX-101.SCH 3045
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE pmn-20231120_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pmn-20231120_pre.xml EX-101.PRE 22380
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2331130d1_8k_htm.xml XML 3410
Mailing Address SUITE 200, 1920 YONGE STREET TORONTO A6 M4S 3E2
Business Address SUITE 200, 1920 YONGE STREET TORONTO A6 M4S 3E2 416-847-6898
ProMIS Neurosciences Inc. (Filer) CIK: 0001374339 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41429 | Film No.: 231420696
SIC: 2834 Pharmaceutical Preparations